[1]
2025. THE IMPACT OF IMMUNOHISTOCHEMICAL MARKER INDICATORS ON TREATMENT OUTCOMES IN ENDOMETRIAL ATYPICAL HYPERPLASIA. World Bulletin of Public Health. 52, (Dec. 2025), 46–50.